Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

U.S. top 10 prescribed drugs based on market share 2019

This statistic depicts the U.S. top 10 prescription drugs based on market share in 2019. In that year, Humira generated some 21 billion U.S. dollars in sales what was equivalent to some 4.2 percent of the U.S. Rx drugs market.

Leading 10 prescription drugs based on U.S. market share in 2019*

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until March 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

August 2020

Region

United States

Survey time period

2019

Supplementary notes

* Market share calculated based on IQVIA's non-discounted spending data. All figures are rounded. Includes prescription and insulin products sold into chain and independent pharmacies, food store pharmacies, mail service pharmacies, long-term care facilities, hospitals, clinics, and other institutional settings. Excludes OTC.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Pharmaceutical industry in Scandinavia "

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.